Kelley School of Business, Indiana University, Indianapolis, IN, USA.
Rawls College of Business, Texas Tech University, Lubbock, TX, USA.
Med Decis Making. 2024 Nov;44(8):880-889. doi: 10.1177/0272989X241275645. Epub 2024 Sep 18.
Information disclosures are used in medicine to provide patients with relevant information. This research examines whether patients are less likely to discuss medical conditions with their physicians after seeing an insurance information disclosure.
Three experimental studies with nonprobability online samples (n = 875 US adult participants) examined the impact of information disclosures on patients' likelihood of disclosing symptoms to providers, using new symptoms and preexisting chronic conditions. The effects of insurance disclosures were also compared to those of pharmaceutical discount disclosures.
These studies demonstrate that information disclosures can result in unintended consequences for patients and providers. Results showed that information disclosures about insurance claims significantly negatively affected willingness to discuss health information with providers. This effect was consistent for both new health concerns, b = -0.661, < 0.001 (study 1, = 250) and b = -0.893, < 0.001 (study 3, = 375), as well as chronic conditions, b = -1.175, < .001 (study 2, = 250); all studies were conducted in January 2023. Information provided to patients about pharmaceutical savings did not similarly affect willingness to discuss symptoms with providers.
These were experimental studies with hypothetical scenarios. Future research is needed to understand how patients react to information disclosures in a physician's office. Future research is also needed to examine the role of specific wording and tone used in information disclosures.
Prior research has shown that patients prefer more information and to be involved in their medical decisions; however, these studies demonstrate that some information disclosures can discourage full communication between patients and physicians.
This research has important implications for the potential consequences of information disclosures in health care settings. Information disclosures should be presented in a way that will not discourage candid discussions of patient symptoms.
This research found that information disclosures about insurance claims can negatively affect patient willingness to discuss health information with providers.Information disclosures may sometimes fall short of their intended purpose of aiding patient decisions with the goal of improved well-being.When information disclosures are focused on warning about potential new costs, patients may feel uncomfortable discussing new symptoms with their providers.Findings suggest patients may often be more concerned with costs than with addressing their ongoing health problems.
信息披露在医学中用于向患者提供相关信息。本研究旨在探讨患者在看过保险信息披露后,是否不太可能与医生讨论医疗状况。
这三项非概率在线样本的实验研究(n=875 名美国成年参与者)使用新症状和预先存在的慢性疾病,考察了信息披露对患者向提供者披露症状可能性的影响。还比较了保险披露和药品折扣披露的效果。
这些研究表明,信息披露可能会给患者和提供者带来意想不到的后果。结果表明,有关保险索赔的信息披露显著降低了患者与提供者讨论健康信息的意愿。对于新的健康问题,b=-0.661,<0.001(研究 1,n=250)和 b=-0.893,<0.001(研究 3,n=375),以及慢性疾病,b=-1.175,<0.001(研究 2,n=250),这一效应均成立;所有研究均于 2023 年 1 月进行。向患者提供有关药品节省的信息不会对与提供者讨论症状的意愿产生类似影响。
这些都是基于假设情景的实验研究。未来的研究需要了解患者在医生办公室中对信息披露的反应。未来的研究还需要研究信息披露中使用的特定措辞和语气的作用。
先前的研究表明,患者更喜欢更多的信息并参与他们的医疗决策;然而,这些研究表明,一些信息披露可能会阻碍患者与医生之间的充分沟通。
这项研究对医疗保健环境中信息披露的潜在后果具有重要意义。信息披露应以不会阻碍患者与医生坦诚讨论症状的方式呈现。
这项研究发现,有关保险索赔的信息披露可能会对患者与提供者讨论健康信息的意愿产生负面影响。信息披露有时可能无法达到帮助患者做出决策以改善健康状况的预期目的。当信息披露侧重于警告潜在的新成本时,患者可能会感到不舒服与他们的提供者讨论新症状。研究结果表明,患者通常更关心成本,而不是解决他们正在面临的健康问题。